Market revenue in 2021 | USD 80.9 million |
Market revenue in 2028 | USD 101.6 million |
Growth rate | 3.3% (CAGR from 2021 to 2028) |
Largest segment | Accu-chek inform ii |
Fastest growing segment | CareSens Expert Plus |
Historical data | 2016 - 2020 |
Base year | 2021 |
Forecast period | 2022 - 2028 |
Quantitative units | Revenue in USD million |
Market segmentation | I-STAT, CareSens Expert Plus, Accu-Chek Inform II, StatStrip, HemoCue |
Key market players worldwide | Roche Holding AG ADR, Abbott Laboratories, Nova Biomedical, Bayer AG, Danaher Corp |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to network point-of-care glucose testing market will help companies and investors design strategic landscapes.
Accu-chek inform ii was the largest segment with a revenue share of 48.21% in 2021. Horizon Databook has segmented the Canada network point-of-care glucose testing market based on i-stat, caresens expert plus, accu-chek inform ii, statstrip, hemocue covering the revenue growth of each sub-segment from 2016 to 2028.
The demand for rapid and preventive diagnosis has been increasing in Canada over the years. The need to develop efficient products aiding in early diagnosis has encouraged local market players to develop glucose testing products that can assist in making better treatment alternatives.
Rapid transition by common people in the country toward self-glucose testing to avoid frequent visits to laboratories has positively influenced the market growth.
Moreover, focus of government organizations on offering appropriate training and spreading awareness pertaining to glucose POC testing products is expected to benefit glucometer users, thereby increasing their demand in the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Canada network point-of-care glucose testing market , including forecasts for subscribers. This country databook contains high-level insights into Canada network point-of-care glucose testing market from 2016 to 2028, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account